Expression, Sorting, and Segregation of Golgi Proteins During Germ Cell Differentiation in the Testis
Overview
Molecular Biology
Authors
Affiliations
The molecular basis of changes in structure, cellular location, and function of the Golgi apparatus during male germ cell differentiation is unknown. To deduce cognate Golgi proteins, we isolated germ cell Golgi fractions, and 1318 proteins were characterized, with 20 localized in situ. The most abundant protein, GL54D of unknown function, is characterized as a germ cell-specific Golgi-localized type II integral membrane glycoprotein. TM9SF3, also of unknown function, was revealed to be a universal Golgi marker for both somatic and germ cells. During acrosome formation, several Golgi proteins (GBF1, GPP34, GRASP55) localize to both the acrosome and Golgi, while GL54D, TM9SF3, and the Golgi trafficking protein TMED7/p27 are segregated from the acrosome. After acrosome formation, GL54D, TM9SF3, TMED4/p25, and TMED7/p27 continue to mark Golgi identity as it migrates away from the acrosome, while the others (GBF1, GPP34, GRASP55) remain in the acrosome and are progressively lost in later steps of differentiation. Cytoplasmic HSP70.2 and the endoplasmic reticulum luminal protein-folding enzyme PDILT are also Golgi recruited but only during acrosome formation. This resource identifies abundant Golgi proteins that are expressed differentially during mitosis, meiosis, and postacrosome Golgi migration, including the last step of differentiation.
CRISPR screens and lectin microarrays identify high mannose N-glycan regulators.
Tsui C, Twells N, Durieux J, Doan E, Woo J, Khosrojerdi N Nat Commun. 2024; 15(1):9970.
PMID: 39557836 PMC: 11574202. DOI: 10.1038/s41467-024-53225-1.
CRISPR screens and lectin microarrays identify novel high mannose N-glycan regulators.
Tsui C, Twells N, Doan E, Woo J, Khosrojerdi N, Brooks J bioRxiv. 2023; .
PMID: 37961200 PMC: 10634773. DOI: 10.1101/2023.10.23.563662.
Elcombe C, Monteiro A, Elcombe M, Ghasemzadeh-Hasankolaei M, Sinclair K, Lea R Environ Toxicol Pharmacol. 2022; 94:103913.
PMID: 35738462 PMC: 9554787. DOI: 10.1016/j.etap.2022.103913.
Riew T, Kim S, Jin X, Kim H, Hwang W, Kang M Cell Tissue Res. 2021; 385(1):191-205.
PMID: 33783608 DOI: 10.1007/s00441-021-03442-7.
Point mutations that inactivate MGAT4D-L, an inhibitor of MGAT1 and complex -glycan synthesis.
Akintayo A, Mayoral J, Asada M, Tang J, Sundaram S, Stanley P J Biol Chem. 2020; 295(41):14053-14064.
PMID: 32763972 PMC: 7549026. DOI: 10.1074/jbc.RA120.014784.